Position in CYTK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$170
-$1,509 QoQ
Shares Held
2
-96.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#468
of 477 holders
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Buck Wealth Strategies, LLC holds $4,724,685 across 28 Biotechnology names. CYTK ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
40,671 | $2,212,909 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,635 | $2,080,775 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673 | $202,593 | |
| 4 | INSM |
INSMED Inc
|
1,899 | $202,471 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15 | $7,450 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $4,988 | |
| 7 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
141 | $4,431 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
22 | $1,638 |
All Filings in CYTK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170 | 2 | Shares | Sole | 2026-07-30 | |
| 2023-09-30 | $1,679 | 57 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,859 | 57 | Shares | Sole | 2023-11-06 | |
| 2023-03-31 | $2,005 | 57 | Shares | Sole | 2023-11-06 | |
| No filing history on record for this holder in this stock. | ||||||